Helloji Holidays (544630)
CyclicalScore breakdown: P/E: 1/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹132 |
| Market Cap | ₹45.28 Cr |
| P/E Ratio | 21.56 |
| ROCE | 64.26% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| Sector | Leisure Services |
Strengths
- Reported ROCE of 64.26% suggests efficient use of capital, if the earnings are genuine.
- P/E of 21.56 is not extreme for an Indian small-cap if earnings were stable.
- Low absolute market cap of ₹45 Cr means a modest absolute profit recovery could have a meaningful per-share effect.
Concerns
- Latest quarter sales and net profit are both ₹0 Cr, making the reported P/E rely on possibly stale or seasonal earnings.
- Piotroski F-Score of 3/9 points to weak financial health.
- Zero dividend yield and zero sales/profit growth offer no income or growth cushion.
- Critical data including book value, debt/equity, and promoter holding are missing, limiting due diligence.
AI Analysis
Helloji Holidays is a small, opaque travel-services company, and that immediately raises my caution. At ₹132, the market cap is ₹45 crore, and the P/E of 21.56 implies roughly ₹2.1 crore of trailing net profit. But the latest quarter shows zero sales and zero net profit. In Graham's framework, earnings must be real and recent; this quarter undermines the entire earnings base. The 64.26% ROCE looks excellent, but without book value or debt/equity data, I cannot verify whether the capital employed is meaningful or whether the ratio is an artifact of a tiny equity base. The zero sales growth, zero profit growth, zero dividend yield, and Piotroski F-Score of 3 out of 9 all point to a fragile financial picture, not a durable compounding franchise. Tour and travel is a competitive, low-moat industry with seasonality and discretionary demand; it does not have the predictability I want in an investment. The missing promoter-holding and book-value figures only add to the uncertainty. FairStock's insufficient-data score is consistent with my view. This is not a stock where I can calculate a margin of safety; at 21.56 times earnings with no current quarter profit, the valuation offers no cushion. I would need to see consistent quarterly revenue, positive profits, and much better disclosure before considering it. Until then, this is a pass.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer